H-10517 for COVID-19

 H-10517 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed H-10517 in detail.
Janin, Y., On the origins of SARS-CoV-2 main protease inhibitors, RSC Medicinal Chemistry, doi:10.1039/d3md00493g
A review on the discovery of relevant SARS-CoV-2 main protease inhibitors along with insights into their origins as well as on which adopted strategies actually delivered and which did not.